标准化粪菌移植技术的临床应用

doi:10.3969/j.issn.1000-8535.2021.03.025

摘要/Abstract

摘要： 目的粪菌移植(fecal microbiota transplantation,FMT)是治疗疾病的新途径,本文总结我院408例(1 085例次)FMT的临床疗效和安全性。FMT治疗艰难梭菌感染有效率达80%,抗生素相关性腹泻68%,炎症性肠病52%,功能性肠病65%,代谢性疾病50%,其他疾病57%,安全性良好,未见严重不良事件发生,结果和多数文献相符。还需更多随机对照试验才能明确FMT的临床价值。

关键词: 粪菌移植, 艰难梭菌感染, 炎症性肠病, 功能性肠病, 代谢性疾病

李永强, 首第文, 徐豪明, 黄红丽, 陈慧婷, 唐文娟, 李瑜元, 周永健. 标准化粪菌移植技术的临床应用[J]. 广州医药, 2021, 52(3): 117-122.

参考文献

[1] van NOOD E, VRIEZE A, NIEUWDORPM, et al. Duodenal infusion of donor feces for recurrent clostridium difficile[J]. N Engl J Med,2013, 368(5):407-415.
[2] CAMMAROTA G, IANIRO G, TILG H, et al. European consensus conference on faecal microbiota transplantation in clinical practice[J]. Gut, 2017,66(4):569-580.
[3] KÖNIG J, SIEBENHAAR A, HÖGENAUER C, et al. Consensus report: faecal microbiota transfer -clinical applications and procedures[J]. Aliment Pharmacol Ther, 2017,45(2):222-239.
[4] NG S C, KAMM M A, YEOH Y K, et al. Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)[J]. Gut, 2020,69(1):83-91.
[5] SARTELLI M, DI BELLA S, MCFARLAND L V, et al. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients[J]. World J Emerg Surg, 2019,14(1):8-29.
[6] WANG H, CUI B, LI Q, et al. The safety of fecal microbiota transplantation for Crohn's disease: findings from a long-term study[J]. Adv Ther, 2018,35(11):1935-1944.
[7] HUANG H L, CHEN H T, LUO Q L, et al. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota[J]. J Dig Dis, 2019,20(8):401-408.
[8] HUANG H, XU H, LUO Q, et al. Fecal microbiota transplantation to treat Parkinson's disease with constipation: a case report[J]. Medicine (Baltimore), 2019,98(26):e16163.
[9] CHEN H, HUANG H, XU H, et al. Fecal microbiota transplantation ameliorates active ulcerative colitis[J]. Exp Ther Med, 2020,19(4):2650-2660.
[10] MCDONALD L C, GERDING D N, JOHNSON S, et al. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)[J]. Clin Infect Dis, 2018,66(7):e1-e48.
[11] 程敬伟,刘文恩,马小军,等. 中国成人艰难梭菌感染诊断和治疗专家共识[J]. 协和医学杂志,2017,(Z1):131-138.
[12] 任荣荣,孙刚,王淑芳,等. 微生态制剂对抗生素相关性腹泻的防治作用[J]. 中华医学杂志,2015,95(6):468-470.
[13] BARTLETT J G. Clinical practice. Antibiotic-associated diarrhea[J]. N Engl J Med, 2002,346(5):334.
[14] 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中华炎性肠病杂志, 2018,2(3):173-174.
[15] SIMREN M, PALSSON O S, WHITEHEAD W E, et al. Update on Rome IV criteria for colorectal disorders: implications for clinical practice[J]. Curr Gastroenterol Rep, 2017,19(4):1-8.
[16] HELLSTRÖM P M, BENNO P. The Rome IV: Irritable bowel syndrome -A functional disorder[J]. Best Pract Res Clin Gastroenterol, 2019(40-41):101634.
[17] 中国成人肥胖症防治专家共识[J]. 中华内分泌代谢杂志, 2011,27(9):711-717.
[18] 非酒精性脂肪性肝病防治指南(2018更新版)[J]. 中华肝脏病杂志, 2018,26(3):195-203.
[19] 中国帕金森病治疗指南(第二版)[J]. 中华神经科杂志, 2009,42(5):352-355.
[20] 朱潇雨,高晋生,王晞星.放射性肠炎诱发及加重因素探究[J]. 癌症进展,2019(13):1501-1502.
[21] SZAJEWSKA H, CANANI R B, GUARINO A, et al. Probiotics for the prevention of antibiotic-associated diarrhea in children[J]. J Pediatr Gastroenterol Nutr, 2016,62(3):495-506.
[22] GREHAN M J, BORODY T J, LEIS S M, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora[J]. J Clin Gastroenterol, 2010,44(8):551-561.
[23] CAO Y, ZHANG B, WU Y, et al. The value of fecal microbiota transplantation in the treatment of ulcerative colitis patients: a systematic review and meta-analysis[J]. Gastroenterol Res Pract, 2018(2018):1-12.
[24] SUN D, LI W, LI S, et al. Fecal microbiota transplantation as a novel therapy for ulcerative colitis: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2016,95(23):e3765.
[25] SHI Y, DONG Y, HUANG W, et al. Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis[J]. PloS one, 2016,11(6):e157259.
[26] FANG H, FU L, WANG J. Protocol for fecal microbiota transplantation in inflammatory bowel disease: a systematic review and meta-analysis[J]. Biomed Res Int, 2018(2018):1-11.
[27] CHEN T, ZHOU Q, ZHANG D, et al. Effect of faecal microbiota transplantation for treatment of clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis of cohort studies[J]. J Crohns Colitis, 2018,12(6):710-717.
[28] LAM W C, ZHAO C, MA W J, et al. The clinical and steroid-free remission of fecal microbiota transplantation to patients with ulcerative colitis: a meta-analysis[J]. Gastroenterol Res Pract, 2019(2019):1-10.
[29] PINN D M, ARONIADIS O C, BRANDT L J. Is fecal microbiota transplantation the answer for irritable bowel syndrome? a single-center experience[J]. Am J Gastroenterol, 2014,109(11):1831-1832.
[30] SOFIE I H, ANDERS W B, STIG G, et al. Can fecal microbiota transplantation cure irritable bowel syndrome?[J]. World J Gastroenterol, 2017,(22):4112-4120.
[31] JOHNSEN P H, HILPÜSCH F, CAVANAGH J P, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial[J]. Lancet Gastroenterol Hepatol, 2018,3(1):17-24.
[32] OHKUSA T, KOIDO S, NISHIKAWA Y, et al. Gut microbiota and chronic constipation: a review and update[J]. Front Med (Lausanne), 2019(6):19.
[33] KUROKAWA S, KISHIMOTO T, MIZUNO S, et al. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study[J]. J Affect Disord, 2018(235):506-512.
[34] TURNBAUGH P J, LEY R E, MAHOWALD M A, et al. An obesity-associated gut microbiome with increased capacity for energy harvest[J]. Nature (London), 2006,444(7122):1027-1031.
[35] ZHANG Z, MOCANU V, CAI C, et al. Impact of fecal microbiota transplantation on obesity and metabolic syndrome-a systematic review[J]. Nutrients, 2019,11(10):2291.
[36] WOODHOUSE C A, PATEL V C, SINGANAYAGAM A, et al. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease[J]. Aliment Pharmacol Ther, 2018,47(2):192-202.
[37] QUIGLEY E M. Microbiota-brain-gut axis and neurodegenerative diseases[J]. Curr Neurol Neurosci Rep, 2017,17(12):1-9.
[38] 李沁芮,韩颖,杜军保,等. 肠道菌群与神经精神系统疾病研究进展[J]. 生理科学进展, 2016,(5):365-368.
[39] 李宁,田宏亮,陈启仪,等. 菌群移植治疗肠道疾病2010例疗效分析[J]. 中华胃肠外科杂志,2019,(9):861-868.
[40] DEFILIP P Z, BLOOM P P, TORRES SOTO M, et al. Drug-resistant e. coli bacteremia transmitted by fecal microbiota transplant[J]. N Engl J Med, 2019,381(21):2043-2050.